Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS

Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS

Treatment of acute respiratory distress syndrome (ARDS) due to COVID-19 pneumonia (CARDS) represents a clinical challenge, requiring often invasive mechanical ventilation (IMV). Since the pathogenesis of CARDS it probably involves a direct viral attack to pulmonary and endothelium cells, and immune-...

Full description

Bibliographic Details
Main Authors: Marco Cascella, Immacolata Mauro, Elvio De Blasio, Anna Crispo, Alfredo Del Gaudio, Sabrina Bimonte, Arturo Cuomo, Paolo Antonio Ascierto
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Medicina
Subjects:
case report
cytokines
immunotherapy
inflammation
COVID-19
acute respiratory distress syndrome (ARDS)
Online Access:https://www.mdpi.com/1010-660X/56/8/377

Internet

https://www.mdpi.com/1010-660X/56/8/377

Similar Items